Article
Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Sept 2013
Rao Arundhati, Sandri Maria Teresa, Sideri Mario, Young Stephen, Sharma Abha, Behrens Catherine
Abstract excerpt
BACKGROUND: The increasing importance of high-risk human papillomavirus (hrHPV) testing in cervical cancer screening warrants evaluation of HPV DNA tests with an equivocal zone requiring retesting of samples in the low positive range. OBJECTIVES: To compare the results of the digene hc2 High Risk HPV DNA Test (hc2), which has a manufacturer's recommended retesting zone with the cobas HPV Test, a real-time...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
